These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36740403)

  • 1. [To stress the importance of physical function on treat-to-target in axial spondyloarthritis].
    Liu XK; Huang F
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):125-128. PubMed ID: 36740403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Axial Spondyloarthritis.
    Winkler AE; Miller M
    Mo Med; 2022; 119(1):79-83. PubMed ID: 36033135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight control and treat-to-target in axial spondyloarthritis. Where are we?
    Wendling D; Claudepierre P; Goupille P; Pham T; Prati C
    Joint Bone Spine; 2022 Jan; 89(1):105263. PubMed ID: 34506936
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the Difficult-to-Treat (D2T) concept applicable to axial spondyloarthritis?
    Wendling D; Verhoeven F; Prati C
    Joint Bone Spine; 2023 May; 90(3):105512. PubMed ID: 36528335
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France.
    Kedra J; Claudepierre P; Flipo RM; Garrido-Cumbrera M; Alliot-Launois F; Desfleurs E; Grange L; Gossec L
    J Rheumatol; 2022 Oct; 49(10):1176-1178. PubMed ID: 35569828
    [No Abstract]   [Full Text] [Related]  

  • 6. Similarities and differences between axial spondyloarthritis and axial psoriatic arthritis.
    Wang W; Lee YH; Wei JC; Mease P
    Int J Rheum Dis; 2023 Mar; 26(3):407-409. PubMed ID: 36645129
    [No Abstract]   [Full Text] [Related]  

  • 7. Healing structural damage in axial spondyloarthritis: are we there yet?
    Proft F; Diekhoff T
    Lancet Rheumatol; 2022 Sep; 4(9):e581-e582. PubMed ID: 38288891
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease Activity Assessment in Nonradiographic Axial Spondyloarthritis: Is It Time to Move Beyond the Bath Ankylosing Spondylitis Disease Activity Index or Ankylosing Spondylitis Disease Activity Score? Comment on the Article by Rusman et al.
    Mishra D; Harish BV; Gadde S; Patro PS
    Arthritis Rheumatol; 2021 Dec; 73(12):2351-2352. PubMed ID: 34180157
    [No Abstract]   [Full Text] [Related]  

  • 9. Work-Related Issues and a High Burden of Disease Are Frequent in Axial Spondyloarthritis: What Should We Be Doing Better?
    Drouet JMS; Gossec L
    J Rheumatol; 2023 May; 50(5):581-582. PubMed ID: 36792108
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on "Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial" by Molto
    Kiltz U; Braun J
    Ann Rheum Dis; 2023 Dec; 82(12):e229. PubMed ID: 34725049
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update".
    Braun J
    Ann Rheum Dis; 2023 Sep; 82(9):e205. PubMed ID: 36737105
    [No Abstract]   [Full Text] [Related]  

  • 12. Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.).
    D'Angelo S
    Clin Exp Rheumatol; 2022 Sep; 40(9):1816. PubMed ID: 36129798
    [No Abstract]   [Full Text] [Related]  

  • 13. Correspondence on: The effects of physical exercise on axial spondyloarthritis - a systematic review.
    Pimentel G; Duarte-Fernandes R; Ferreira RJO
    ARP Rheumatol; 2024; 3(1):75-76. PubMed ID: 38557830
    [No Abstract]   [Full Text] [Related]  

  • 14. Current aspects for the treatment of axial spondyloarthritis.
    Ku CH; Lee YH; Wei JC; Braun J
    Int J Rheum Dis; 2023 Jan; 26(1):5-7. PubMed ID: 36591903
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of mucosal-associated invariant T cells in blood of patients with axial spondyloarthritis and in axial entheses of healthy controls: comment on the article by Rosine et al.
    Toussirot E; Laheurte C; Saas P
    Arthritis Rheumatol; 2022 Dec; 74(12):2045-2046. PubMed ID: 35762820
    [No Abstract]   [Full Text] [Related]  

  • 16. Correspondence on: The effects of physical exercise on axial spondyloarthritis - a systematic review - REPLY.
    Santos ME; Gonçalves NP; Silvério-António M; Donato H; Pimentel-Santos F; Cruz E
    ARP Rheumatol; 2024; 3(1):77-78. PubMed ID: 38557481
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng.
    Molto A; van der Heijde D; Van den Bosch FE; Dougados M
    Ann Rheum Dis; 2023 Jul; 82(7):e167. PubMed ID: 34187778
    [No Abstract]   [Full Text] [Related]  

  • 18. Clearing the fog: A closer look at the differences between axial psoriatic arthritis and axial spondyloarthritis.
    Benavent D; Navarro-Compán V
    ARP Rheumatol; 2023; 2(1):3-6. PubMed ID: 37042843
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge of new classification criteria for axial spondyloarthritis.
    Khan MA; Yong SB; van der Linden S
    Int J Rheum Dis; 2023 Jul; 26(7):1225-1226. PubMed ID: 37394892
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in axial spondyloarthritis: Learning from the leaders.
    Ramiro S; Haroon N
    Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101877. PubMed ID: 37985319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.